DocGo Inc. Common Stock (DCGO)

FairStock Score: 41/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

DocGo operates mobile healthcare and medical transport services. In fiscal year 2025, the year ended 2025-12-31, it reported revenue of $322.2 million and a net loss of $182.4 million, or diluted EPS of -$1.84. That followed fiscal 2024 revenue of $616.6 million and net income of $20.0 million, and fiscal 2023 revenue of $624.3 million and net income of $6.9 million. Revenue roughly halved, and profits turned into heavy losses. In fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $73.4 million and net loss was $15.8 million. The latest quarter margin was -21.55%, so the pain continues. As a Buffett/Graham investor, I look for durable competitive advantage. I see little evidence of one. Medical transport and mobile health can be contract-driven and competitive. FairStock calculations show return on equity of -107.79%, return on capital employed of -19.81%, and a Piotroski F-score of 2/9. Trailing free cash flow is -$28.6 million, with an FCF yield of -94.9% against market cap. The Altman Z-score of -1.03 points to distress risk. Debt/equity of 0.27 is not alarming by itself, but cash burn is. At the $0.31 close on 2026-10-13, FairStock calculates a market cap of $30.2 million and P/B of 0.25. A low price-to-book can attract Graham followers, but book value can shrink when losses persist. The Lynch category is TURNAROUND - loss in the latest year after earlier profits. Turnarounds need stabilizing revenue and improving cash flow; neither is visible yet. I require tangible evidence before treating this as a value opportunity rather than a falling knife.

In plain English: DocGo provides mobile healthcare and medical transport services. The business looks weak right now: sales have fallen a lot and the company is losing money. The stock price is very low compared with its accounting value, but the losses and cash use make it hard to call the shares a clear bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer